Record · engineering.vanderbilt.edu
Asheley Chapman develops targeted therapeutics aimed at altering white blood cells to treat diseases
engineering.vanderbilt.edu · 1 July 2026 · 4 min read
A post on engineering.vanderbilt.edu, published 1 July 2026, has not been cited by any blog yet (corpus.blog, measured 11 October 2026).
A record is what was published and who pointed at it. The text of the post is not shown here: read it at the source, or at its Wayback capture.
0blogs citing
| Period | Blogs | Links |
|---|---|---|
| All time | 0 | 0 |
| Last 90 days | 0 | 0 |
| Last 30 days | 0 | 0 |
| Last 7 days | 0 | 0 |
| Words blogs link it with | 0 |
|---|---|
| External links | 0 |
| Length | 787 |
Cited by
No blog we hold has cited this post yet.
Links from this post
This post only links within engineering.vanderbilt.edu.
Elsewhere on engineering.vanderbilt.edu (1)
engineering.vanderbilt.edu
Similar posts
2 Oct 2026
17 Apr 2026
Meet the 2026 STARs: Aaron Whiteley, PhD
cancerresearch.org
14 Aug 2026
MSTPublications July 2026
medschool.vanderbilt.edu
30 Jul 2026
How Triple-Negative Breast Cancer Sends Secret Messages to Silence the Immune System
communities.springernature.com
7 Oct 2026
What Is Antibody Mediated Immunity?
biologyinsights.com
3 Oct 2026
Listeria Bacteria Leads to Unique Cancer Therapy
vcresearch.berkeley.edu
9 Jul 2026
This Vaccine Just Changed Cancer Forever
drstanfield.com
25 Aug 2026
The PBMC Assay: How It Advances Health Research
biologyinsights.com
3 Oct 2026
Something wrong here? Report a problem